Related Experiment Video
Updated: Nov 8, 2025

07:16
Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach
Published on: April 25, 2025
518
National Institutes of Health Advancing Multimorbidity Research
Marcel E Salive1, Jerry Suls2, Tilda Farhat3
1Geriatrics Branch, National Institute on Aging, Bethesda, MD.
Medical Care
|April 26, 2021
Summary
Multimorbidity, the presence of multiple chronic diseases, is common in older adults. Researching multimorbidity requires a patient-centered framework to understand causes, interactions, and improve treatment outcomes.
Area of Science:
- Gerontology
- Chronic Disease Epidemiology
- Health Services Research
Background:
- Multimorbidity, defined as the co-occurrence of two or more chronic diseases, is prevalent, particularly in individuals aged 65 and older.
- Understanding and measuring multimorbidity is crucial for advancing research into its causes, interactions, and effective management.
- Routine assessment of multimorbidity can lead to improved patient outcomes and more effective treatment strategies.
Purpose of the Study:
- To introduce a comprehensive research framework for studying multimorbidity.
- To identify existing gaps within the current body of multimorbidity research.
- To guide future research directions and enhance the understanding of complex disease interactions.
Main Methods:
- A literature review was conducted to inform the development of a guiding framework.
- An expert panel workshop was convened in September 2018 to discuss multimorbidity research.
- The framework was developed based on a patient-centered approach, incorporating concepts like concordant and discordant comorbidity.
Main Results:
- The developed framework integrates patient-centered principles, considering concordant and discordant comorbidities.
- The framework facilitates the identification of potential causes, disease interactions, and patient outcomes.
- Workshop discussions focused on selecting optimal multimorbidity assessment instruments and defining future research priorities.
Conclusions:
- Advancing multimorbidity research necessitates addressing limitations in study designs and target populations.
- Increased emphasis on standardized, universal outcome measures is essential for comparative research.
- Implementing the proposed framework can significantly contribute to a more robust understanding and management of multimorbidity.

